Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B I Carr

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Cancer Research|July 1, 1984
Effect of 2-acetylaminofluorene on the binding of epidermal growth factor to microsomal and Golgi fractions of rat liver cellsZ Josefsberg, B I Carr, D Hwang, et al.
Cancer|July 15, 1991
Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 casesJ C Flickinger, A H Epstein, S Iwatsuki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2005
Clinically meaningful changes in health-related quality of life in patients diagnosed with hepatobiliary carcinomaJ L Steel, D T Eton, D Cella, et al.
American Journal of Clinical Oncology|December 1, 1989
Combination chemotherapy with cytosine arabinoside (Ara-C) and cis-diamminedichloroplatinum (CDDP) for squamous cancers of the upper aerodigestive tractK Margolin, J Doroshow, L Leong, et al.
Japanese Journal of Gastroenterology and Hepatology|May 20, 2026
Prognostic Factor and Serum Biomarker Changes in Non-Surgical Hepatocellular Carcinoma Patients Treated with RadioembolizationB I Carr, H G Gozukara Bag, R Kutlu, et al.
Digestive Diseases and Sciences|September 18, 1999
ERCP and stent therapy for progressive jaundice in hepatocellular carcinoma: which patients benefit, which patients don't?J A Martin, A Slivka, M Rabinovitz, et al.
AJR. American Journal of Roentgenology|February 1, 1995
Does advanced cirrhosis with portosystemic shunting affect the value of CT arterial portography in the evaluation of the liver?J H Oliver, R L Baron, G D Dodd, et al.
Hepatology (Baltimore, Md.)|May 1, 1992
Effects of rapamycin on cultured hepatocyte proliferation and gene expressionA Francavilla, B I Carr, T E Starzl, et al.
Cancer Research|August 1, 1987
Fetal hemoglobin gene activation in a phase II study of 5,6-dihydro-5-azacytidine for bronchogenic carcinomaB I Carr, S Rahbar, J H Doroshow, et al.
Cancer|November 1, 1987
High doses of prochlorperazine for cisplatin-induced emesis. A prospective, random, dose-response studyB I Carr, D W Blayney, D A Goldberg, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Cancer Research|July 1, 1984
Effect of 2-acetylaminofluorene on the binding of epidermal growth factor to microsomal and Golgi fractions of rat liver cellsZ Josefsberg, B I Carr, D Hwang, et al.
Cancer|July 15, 1991
Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 casesJ C Flickinger, A H Epstein, S Iwatsuki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2005
Clinically meaningful changes in health-related quality of life in patients diagnosed with hepatobiliary carcinomaJ L Steel, D T Eton, D Cella, et al.
American Journal of Clinical Oncology|December 1, 1989
Combination chemotherapy with cytosine arabinoside (Ara-C) and cis-diamminedichloroplatinum (CDDP) for squamous cancers of the upper aerodigestive tractK Margolin, J Doroshow, L Leong, et al.
Japanese Journal of Gastroenterology and Hepatology|May 20, 2026
Prognostic Factor and Serum Biomarker Changes in Non-Surgical Hepatocellular Carcinoma Patients Treated with RadioembolizationB I Carr, H G Gozukara Bag, R Kutlu, et al.
Digestive Diseases and Sciences|September 18, 1999
ERCP and stent therapy for progressive jaundice in hepatocellular carcinoma: which patients benefit, which patients don't?J A Martin, A Slivka, M Rabinovitz, et al.
AJR. American Journal of Roentgenology|February 1, 1995
Does advanced cirrhosis with portosystemic shunting affect the value of CT arterial portography in the evaluation of the liver?J H Oliver, R L Baron, G D Dodd, et al.
Hepatology (Baltimore, Md.)|May 1, 1992
Effects of rapamycin on cultured hepatocyte proliferation and gene expressionA Francavilla, B I Carr, T E Starzl, et al.
Cancer Research|August 1, 1987
Fetal hemoglobin gene activation in a phase II study of 5,6-dihydro-5-azacytidine for bronchogenic carcinomaB I Carr, S Rahbar, J H Doroshow, et al.
Cancer|November 1, 1987
High doses of prochlorperazine for cisplatin-induced emesis. A prospective, random, dose-response studyB I Carr, D W Blayney, D A Goldberg, et al.
Pageof 11